Table 3 Average AUC/c-index for individual and combined models with all the lesions, HCC lesions, and metastasis lesions
OR model | Average AUC (95 % confidence intervals) | ||
|---|---|---|---|
All (105) | Primary HCC (35) | Metastasis (70) | |
 Radiomics (ZP) | 0.713 (0.685–0.741) | 0.762 (0.680–0.834) | 0.658 (0.623–0.693) |
 Absorbed dose | 0.713(0.678–0.746) | 0.717 (0.642–0.786) | 0.696 (0.654–0.737) |
 Combined (dose + ZP) | 0.729 (0.702–0.758) | 0.734 (0.660–0.802) | 0.692 (0.653–0.723) |
Progression model | Average c-index (95% confidence intervals) | ||
All (103) | Primary HCC (35) | Metastasis (68) | |
 Radiomics (ZSN) | 0.694 (0.676–0.710) | 0.565 (0.528–0.598) | 0.656 (0.629–0.680) |
 Absorbed dose | 0.754 (0.742–0.766) | 0.613 (0.585–0.635) | 0.719 (0.700–0.737) |
 Combined (dose + ZSN) | 0.803 (0.790–0.815) | 0.638 (0.610–0.661) | 0.762 (0.740–0.780) |
ADASYN progression model | Average c-index (95% confidence intervals) | ||
All (103) | Primary HCC (35) | Metastasis (68) | |
 Radiomics (ZSN) | 0.712 (0.698–0.726) | NA | 0.595 (0.575–0.615) |
 Absorbed dose | 0.771 (0.762–0.781) | NA | 0.726 (0.713–0.739) |
 Combined (dose + ZSN) | 0.794 (0.785–0.803) | NA | 0.728 (0.716–0.740) |